This paper studies the global dynamics of a general diffusive hepatitis B virus (HBV) infection model. The model includes both enveloped viruses and DNA containing capsids. Two immune responses are recruited to attack the virus and infected hepatocytes. These are the cytotoxic T-lymphocytes (CTL) which kill the infected liver cells, and B cells which send antibodies to attack the virus. The non-negativity and boundedness of the solutions are discussed. The existence of spatially homogeneous equilibrium points is examined. The global stability of all possible equilibrium points is proved by choosing suitable Lyapunov functionals. Some numerical simulations are performed to enhance the theoretical results and present the behavior of solutions in space and time.
their motion may have a critical role in biological systems [20] . After that, many works have started to incorporate spatial diffusion into the biological models in order to make them more realistic. For example, Wang and Wang [21] assumed that the movement of the HBV follows the Fickian diffusion [22] and studied the following model:
∂V (x,t) ∂t
where U(x, t), I(x, t), and V (x, t) represent the densities of uninfected hepatocytes, infected hepatocytes, and free HBV at position x and time t, respectively. The target cells are produced at rate λ, die at rate dU, and are converted into infected cells at rate γ UV . The infected cells die at rate αI, while the viruses die at rate mV . The viruses diffuse with a diffusion coefficient d V and are generated from infected cells at rate kI. In the diffusion term, V = ∂ 2 V ∂x 2 is the Laplacian operator. Xu and Ma [23] studied a diffusive HBV model with time delay and saturation infection rate. Shaoli et al. [24] investigated an HBV infection model with virus diffusion and nonlinear infection rate. Zhang and Xu [25] considered a delayed HBV model with Beddington-DeAngelis infection rate and diffusion. Miao et al. [6] developed an infection model consisting of five partial differential equations, time delays, and adaptive immunity. In a very recent work, Bellomo and Tao [26] studied a viral infection model with diffusion induced by chemotaxis dynamics. More recently, many works have added an explicit equation for HBV nucleocapsids to some HBV infection models. For example, Geng et al. [27] considered the mobility of capsids and viruses and applied the nonstandard finite difference (NSFD) scheme to discretize a continuous HBV infection model with capsids. Their work was an extension to the work of Manna and Chakrabarty [28] . Guo et al. [29] studied an HBV infection model which contains three time delays, capsids, general incidence rate, and allows the movement of viruses by diffusion. Manna [30] investigated the role of the CTL immune response in a reaction-diffusion model of HBV with capsids. Notably, none of the aforementioned models considered both capsids and adaptive immune response.
In a very recent work, Danane and Allali [31] explored an HBV infection model with capsids and adaptive immunity. However, the spatial mobility of viruses was ignored and the global stability of the equilibria was not analyzed. The production and death rates were given by linear functions which may not describe the real situation during the infection process [32] . The stimulation rates of immune cells and the removal rates were given by bilinear functions. Also, the interaction between healthy cells and viruses was given by a bilinear incidence function. In fact, the bilinear incidence rate is not adequate to reflect the actual interaction between uninfected cells and viruses [8, 32] . In addition, it indicates that the person with a larger liver is more sensitive to HBV than a person with a smaller liver size, which seems unrealistic [29, 33] . In this paper, we study the basic and global properties of a diffusive hepatitis B virus infection model with viral capsids and two types of immune responses. The production, stimulation, infection, removal, and death rates are given by general functions. The paper is organized as follows. In Sect. 2, we explain the model and its requirements. In Sect. 3, we show some basic properties like boundedness and existence of equilibrium points. In Sect. 4, we analyze the global stability of all possible equilibrium points. In Sect. 5, we perform some numerical simulations to support the obtained theoretical results. The conclusion is stated in Sect. 6.
A diffusive HBV dynamics model with capsids and adaptive immune response
Motivated by the work of [6, 13, 30, 31] , we study the following general HBV infection model with capsids and two forms of adaptive immune response:
where U(x, t), I(x, t), C(x, t), V (x, t), Z(x, t), and W (x, t) stand for the densities of uninfected hepatocytes, infected hepatocytes, HBV nucleocapsids, HBV particles, CTLs, and B cells at location x and time t, respectively. The function Θ(U) is the intrinsic growth rate including both the production and death rates of hepatocytes. The function Π(U, V ) gives the rate at which the uninfected hepatocytes become infected. The infected cells are killed by CTLs at rate δΦ 1 (I)Φ 4 (Z) and die at rate αΦ 1 (I). The coefficient d C is the diffusion coefficient of capsids. The virus capsids are produced from infected liver cells at rate bΦ 1 (I) and used to form enveloped virus particles at rate βΦ 2 (C). The capsids and viruses die at rates αΦ 2 (C) and mΦ 3 (V ), respectively. Viruses are neutralized by antibodies at rate rΦ 3 (V )Φ 5 (W ). CTLs are stimulated in response to antigens at rate pΦ 1 (I)Φ 4 (Z), while B cells are stimulated to produce antibodies at rate qΦ 3 (V )Φ 5 (W ). The CTL and B immune cells die at rates σ Φ 4 (Z) and μΦ 5 (W ), respectively. For model (2) , we consider the following initial conditions:
and homogeneous Neumann boundary conditions
The functions ψ i (i = 1, . . . , 6) are Hölder continuous inΩ. The domain Ω is connected and bounded with a smooth boundary ∂Ω. In addition, ∂ ∂ n represents differentiation in the direction of the outward normal to the boundary ∂Ω. The Neumann boundary conditions imply that no virus particles or capsids pass through or exit the boundary.
The general functions Θ, Π , and Φ i (i = 1, . . . , 5) are continuous, differentiable and meet the following requirements:
[Q1] (i) Θ (U) < 0 for all U > 0, (ii) there exists U 0 > 0 such that Θ(U 0 ) = 0, and Θ(U) > 0 for all U ∈ [0, U 0 ), (iii) there are two parameters κ 1 > 0 and κ 2 > 0 such that
Fundamental properties
This section discusses some fundamental properties of the solutions of model (2)-(4) to be biologically valid. These properties include the existence, positivity, and boundedness of the solutions. Also, we show that model (2) Proof Let X = BUC(Ω, R 6 ) be the set of all bounded and uniformly continuous functions fromΩ to R 6 , and let X + = BUC(Ω, R 6 + ) ⊂ X. The positive cone X + induces a partial order on X. Let | · | be the Euclidean norm on R 6 , and let ω X = sup x∈Ω |ω(x)|. This implies that (X, · X ) is a Banach lattice [25, 34] .
For any initial data ψ = (ψ 1 , ψ 2 , ψ 3 , ψ 4 , ψ 5 , ψ 6 ) ∈ X + , we define F = (F 1 , F 2 , F 3 , F 4 , F 5 , F 6 ) :
It is clear that F is locally Lipschitz on X + . We can rewrite system (2)-(4) as the following abstract functional differential equation:
where H = (U, I, C, V , Z, W ), AH = (0, 0, d C C, d V V , 0, 0) T , and ψ = (ψ 1 , ψ 2 , ψ 3 , ψ 4 , ψ 5 , ψ 6 ). One can show that
It follows from [25, 34, 35] that, for any ψ ∈ X + , system (2)-(4) has a unique non-negative mild solution on [0, T l ), where [0, T l ) is the maximal existence time interval. Now, we show the boundedness of the solutions. Take
Using requirements [Q1] and [Q3] with model (2) leads to
where s 1 = min{κ 2 , αρ 1 , σρ 4 }. Thus,
which implies that U(x, t), I(x, t), and Z(x, t) are bounded. Moreover, from the boundedness of I(x, t), the third equation of (2) and [Q3], we get
Let C(t) be a solution to the following ordinary differential equation:
Hence, it follows that C(t) ≤ max{ bΦ 1 (ζ 1 ) (α+β)ρ 2 , max x∈Ω ψ 3 (x)}. According to the comparison principle [36] , C(x, t) ≤ C(t). So,
Finally, we prove the boundedness of V (x, t) and W (x, t). Using the boundedness of C(x, t) and from model (2)-(4), we find that V (x, t) satisfies the following system:
Let V (t) be a solution to the following system:
then using [Q3], we obtain
Thus, the above discussion assures the boundedness of U(x, t), I(x, t), C(x, t), V (x, t), Z(x, t), and W (x, t) onΩ × [0, T l ). Then the boundedness of the solutions onΩ × [0, +∞) follows from the standard theory for semi-linear parabolic systems [37] where T l = +∞. Proof Any equilibrium point M = (U, I, C, V , Z, W ) of system (2) satisfies the following equilibrium conditions:
From Eq. (9) we get (pΦ 1 (I)σ )Φ 4 (Z) = 0, which gives two possible options
Also, from Eq. (10) we have (qΦ 3 (V )μ)Φ 5 (W ) = 0, which gives two possible options
Then, according to (11) and (12), there are four cases: Case 1. If Φ 4 (Z) = 0 and Φ 5 (W ) = 0, then by [Q3] we get Z = 0 and W = 0. Thus, equilibrium conditions (5)-(10) are reduced to
From Eqs. (13)-(16) we obtain the following relations:
and
We can conclude from [Q3] that Φ -1 i (i = 1, . . . , 5) exist, strictly increasing and Φ -1 i (0) = 0. Then we define
Hence, it follows from (18) and (19) that
We note from [Q1] that Γ 1 (U 0 ) = Γ 2 (U 0 ) = Γ 3 (U 0 ) = 0. Equations (17)- (20) give
Using Eq. (20) along with requirements [Q1]-[Q3], we can see that Eq. (21) admits a solution U = U 0 , and this gives the disease-free equilibrium M 0 = (U 0 , 0, 0, 0, 0, 0). Denote
Based on [Q1]-[Q3], we find
Now, in order to have a root in the interval (0, U 0 ), we need to show that χ 1 (U 0 ) < 0.
Since ∂Π(U 0 ,0) ∂U = 0 by [Q2], then from (18) and (20) we get
where R 0 is the basic reproduction number and is given by
As Θ (U 0 ) < 0 by [Q1], then χ 1 (U 0 ) < 0 if R 0 > 1. Therefore, when R 0 > 1, there exists a root U 1 ∈ (0, U 0 ) such that χ 1 (U 1 ) = 0. From Eq. (20) and requirements [Q1]-[Q3], the corresponding components are
Thus, the immune-free equilibrium M 1 = (U 1 ,
In other words, the threshold condition R 0 > 1 is needed for the infection point M 1 to exist in the absence of immune responses. Case 2. If Φ 3 (V ) = μ q and Φ 4 (Z) = 0, then the third requirement [Q3] implies that
Then, with the aid of [Q1] and [Q2] we get
Accordingly, there exists a unique root U 2 ∈ (0, U 0 ) of (23) such that χ 2 (U 2 ) = 0. From Eq. (20) and [Q1]-[Q3], we get
Finally, from Eqs. (5)-(8) we obtain
where R 1 is defined as
.
R 1 is the threshold number needed for activating the antibody immune response against viruses. Hence, the infection equilibrium with only antibody immune defense
, we can note that
Case 3. If Φ 1 (I) = σ p and Φ 5 (W ) = 0, we get
Then Eqs. (7) and (8) give
According to requirements [Q1] and [Q2], χ 3 (U) is strictly decreasing and
where R 2 is given by
Here, R 2 represents the activation number for CTL immune defense. Thus, the infection equilibrium without antibody immune response M 3 = (U 3 ,
, it is easy to note that
Then Eq. (7) gives
Replace V by V 4 in Eq. (5) and define
Using [Q1] and [Q2], we can see that χ 4 (U) is strictly decreasing, χ 4 (0) > 0 and χ 4 (U 0 ) < 0. Thus, there exists a unique root U 4 ∈ (0, U 0 ) such that χ 4 (U 4 ) = 0. Eq. (6) is used to obtain
where R 3 is a threshold parameter defined by
Finally, Eq. (8) is used to get
where R 1 R 3 is given by
Thus, the infection equilibrium with CTL and antibody immune defense
That is, the two immune responses work together to fight the virus when R 1 > R 3 > 1.
Global stability
In this section we study the global stability of the five equilibrium points M 0 , M 1 , M 2 , M 3 , and M 4 of system (2) by using the Lyapunov method.
Then we get
By using Θ(U 0 ) = 0, [Q1] and [Q4], we get
The time derivative of Λ 0 (t) along the positive solutions of (2) is given by
From the divergence theorem and (4), we have
In addition, we deduce from [Q1] and [Q2] that
Accordingly, Eq. (24) is reduced to
Hence, dΛ 0 dt ≤ 0 if R 0 ≤ 1. Moreover, dΛ 0 dt = 0 when U = U 0 , V = 0, Z = 0, and W = 0. It follows from system (2) that I = 0 and C = 0. Accordingly, the largest invariant set in {(U, I, C, V , Z, W ) : dΛ 0 dt = 0} is the singleton {M 0 }. Thus, by LaSalle's invariance principle [38] , the infection-free equilibrium M 0 is globally asymptotically stable when R 0 ≤ 1.
Proof From [Q1], [Q2], and [Q4], we can conclude the following relations:
for U 1 , U 2 , V 1 , V 2 > 0. Assume by contradiction that sgn(U 2 -U 1 ) = sgn(V 2 -V 1 ). By using Eq. (5), we get
Consequently, from (26)- (28) we have sgn(U 1 -U 2 ) = sgn(U 2 -U 1 ), which is a contradiction. This implies that
Moreover, using (17) and (18) with the definition of R 1 gives
Thus, from (27)- (29) we have
Proof From [Q1], [Q2], and [Q4], we have
From the equilibrium conditions of M 1 and M 3 , we get
which implies that sgn(V 1 -V 3 ) = sgn(I 1 -I 3 ). Using (30)-(33) and following the same strategies used for proving Lemma 1, we can show that
and Proof Introduce a Lyapunov functional
At the equilibrium point M 1 , we have
Thus, (34) can be rewritten as follows:
Thus, the derivative of Λ 1 (t) with respect to t is given by
We can deduce from the divergence theorem and Neumann boundary conditions that
Rearranging and using [Q3], we get
Similarly, we get
Using (25), (36) , and (37), we get
From the model requirements [Q1]-[Q4], we obtain
Using Lemma 1 and 2 and [Q3], we have
Using the relation between geometrical and arithmetical means, we have
The above arguments imply that dΛ 1 dt ≤ 0 if R 1 ≤ 1 and R 2 ≤ 1. It is easy to check that dΛ 1 dt = 0 at M 1 = (U 1 ,
Hence, when R 1 ≤ 1 < R 0 and R 2 ≤ 1 < R 0 , M 1 exists and LaSalle's invariance principle [38] assures its global asymptotic stability.
Theorem 5 The infection equilibrium with only antibody immune response M
Proof Consider a Lyapunov functional
This leads to
From the equilibrium conditions of M 2 , we observe
After collecting terms of (40) and using (41), we get
Now, taking the time derivative of Λ 2 (t) and applying (25) and (36) with (37) give
Using the equilibrium points M 2 and M 4 , we have
Since V 2 = V 4 , then by Theorem 2 we have U 2 = U 4 . This implies that
Hence, we obtain
Then, using similar justifications to those given in (38) and (39), we find that Proof Take a Lyapunov functional as
Then we have
By using the equilibrium conditions at M 3
and collecting terms of (42), we have
Then, by using (25), (36) , and (37), the derivative of Λ 3 (t) with respect to time is given by
Using the equilibrium points M 3 and M 4 , we have
,
The other terms are less than or equal to zero for the same reasons given in (38) and
Following the proof of Theorem 5, one can prove that dΛ 3 dt = 0 at M 3 = (U 3 , I 3 , C 3 , V 3 , Z 3 , 0) and thus {M 3 } is the largest invariant subset of {(U, I, C, V , Z, W ) : dΛ 3 dt = 0}. By LaSalle's invariance principle [38] , the equilibrium point M 3 is defined and globally asymptotically stable if R 2 > 1 and R 1 R 3 ≤ 1. Proof Define a Lyapunov functional
Then we obtain
By using the equilibrium conditions at M 4
and collecting terms of (43), we have
Then, by using (25) , (36) , and (37) , the time derivative of Λ 4 (t) is given by 
From (38) and (39) [38] , where the point exists if R 1 > R 3 > 1.
Numerical simulations
Our goal in this section is to carry out some numerical simulations which exhibit the global stability of all equilibrium points of the model. We consider the following special case of model (2):
In model (44) , the functions Θ, Π , and Φ i (for i = 1, . . . , 5) are taken to be
where the infection rate Π(U, V ) is the Beddington-DeAngelis functional response [25, 42, 43] . It is straightforward to check that all requirements [Q1]-[Q4] are satisfied. We assume the following initial conditions:
U(x, 0) = 500 cells mm -3 , I(x, 0) = 1.5 cells mm -3 , 
Z(x, 0) = 1.5 cells mm -3 , W (x, 0) = 1 cells mm -3 , x ∈ [0, 1], and homogeneous Neumann boundary conditions ∂C ∂ n = 0, ∂V ∂ n = 0, for t ∈ [0, 500], x = 0, 1.
The initial values are arbitrarily chosen as the global stability of the equilibrium points guarantees the convergence regardless of the selected initial conditions. The threshold parameters R 0 , R 1 , R 2 , and R 3 are given by
, where
For the numerical simulations of system (44)- (46) , the values of γ , p, μ, and ς 1 are changed as they have the most important effects on the global stability of equilibrium points. The values of all other parameters are fixed in Table 1 . We have chosen the parameters of the model to perform the numerical simulations. This is because of the difficulty of getting real data from HBV infected patients; however, if one has real data, then the parameters of the model can be estimated and the validity of the model can be established. The results can be divided into the following categories: (i) When γ = 0.9 mm 3 virus -1 day -1 , p = 0.2 mm 3 cell -1 day -1 , μ = 0.1 day -1 and ς 1 = 1 mm 3 cell -1 , then we get R 0 = 0.0524 < 1. In this case, the solutions of system (44) asymptotically approach M 0 = (1000, 0, 0, 0, 0, 0) as can be seen in Fig. 1 . (iii) We take γ = 0.5 mm 3 virus -1 day -1 , p = 0.01 mm 3 cell -1 day -1 , μ = 0.5 day -1 and (iv) If γ = 0.5 mm 3 virus -1 day -1 , p = 0.07 mm 3 cell -1 day -1 , μ = 0.5 day -1 and ς 1 = 0.01 mm 3 cell -1 , then we obtain R 0 = 2.6515 > 1, R 2 = 2.4515 > 1, and R 1 R 3 = 0.3 < 1. For this choice of parameter values, the solutions of system (44) converge to the infection equilibrium M 3 = (579.4083, 2.775, 0.5546, 0.097, 0.8672, 0), which supports Theorem 6. The results are shown in Fig. 4 . In this situation, CTL immune response works alone to kill the infected cells which are the source of the virus. (v) When γ = 0.7 mm 3 virus -1 day -1 , p = 0.15 mm 3 cell -1 day -1 , μ = 0.06 day -1 and ς 1 = 0.01 mm 3 cell -1 , then we get R 0 = 3.7121 > 1, R 3 = 3.0757 > 1, R 1 R 3 = 1.1667 > 1. In agreement with Theorem 7, we can see from Fig. 5 that the equilibrium M 4 = (753.4535, 1.3449, 0.2708, 0.0406, 1.2688, 1.5117) is globally asymptotically stable. Here, CTL and antibody immune responses work in parallel to kill the infected hepatocytes and attack the HBV, respectively. As a result, the number of healthy liver cells increases while the numbers of infected cells, capsids, and viruses decrease.
Conclusion
In this paper, we have studied a diffusive HBV infection model with capsids and two forms of immune responses, the CTL and antibody immune responses. We have shown that the model has five equilibrium points which are given by the disease-free equilibrium M 0 , the immune-free equilibrium M 1 , the infection equilibrium with only antibody immune response M 2 , the infection point with only CTL immune response M 3 , and the equilibrium with both types of adaptive immunity M 4 . The conditions for existence and global stability of these equilibrium points have produced four threshold parameters R 0 , R 1 , R 2 , and R 3 . The equilibrium point M 0 is globally asymptotically stable if R 0 ≤ 1, which indicates that the liver cells are totally healthy and there is no infection. The equilibrium M 1 exists and is globally asymptotically stable if R 1 ≤ 1 < R 0 and R 2 ≤ 1 < R 0 , and it reflects the situation when the immune responses have not been activated yet to counter the infection. The infection equilibrium M 2 exists and is globally asymptotically stable if R 1 > 1 and R 3 ≤ 1, where only B lymphocytes work to defeat the virus. On the other hand, M 3 exists and is globally asymptotically stable equilibrium point if R 2 > 1 and R 1 R 3 ≤ 1. In this case, only CTLs try to clear the infection by killing the infected hepatocytes. Finally, B and T immune cells work together to eliminate HBV infection at the equilibrium M 4 that exists and is globally asymptotically stable if R 1 > R 3 > 1. The provided numerical simulations have supported the theoretical results and showed the spatiotemporal behavior of the solutions.
It is commonly observed that in viral infection processes, time delay is inevitable (see, e.g., [8] [9] [10] [11] [44] [45] [46] [47] ). Extending model (2) to include the effect of treatments and time delays will give a deeper insight into HBV infection. Another extension of model (2) is to incorporate stochastic interactions (see [48] ). We leave these points as future works.
